The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 10, 2022

Filed:

Aug. 11, 2017
Applicant:

Korea Food Research Institute, Gyeonggi-do, KR;

Inventors:

Young-Do Nam, Gyeonggi-do, KR;

Yun-Tai Kim, Gyeonggi-do, KR;

Hee Soon Shin, Gyeonggi-do, KR;

So-Young Lee, Gyeonggi-do, KR;

Jae-Goo Kim, Gyeonggi-do, KR;

Eun-Yeong Lim, Chungcheongnam-do, KR;

Eun-Ji Song, Busan, KR;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/747 (2015.01); A61K 35/00 (2006.01); A23L 33/135 (2016.01); A61P 5/24 (2006.01); C12N 1/20 (2006.01); C12R 1/225 (2006.01);
U.S. Cl.
CPC ...
A61K 35/747 (2013.01); A23L 33/135 (2016.08); A61P 5/24 (2018.01); C12N 1/20 (2013.01); A61K 2035/115 (2013.01); C12R 2001/225 (2021.05);
Abstract

The present invention relates to: a novelYT2 strain (deposition number: KCCM11812P); and a composition for preventing, alleviating, or treating menopause, comprising, as an active ingredient,comprising the novel strain. The present inventors have established an animal model for menopause through ovariectomy, confirmed changes of the distribution of intestinal microorganisms by the model, identified and isolated a novelstrain among lactic acid bacteria of which the distribution is significantly reduced in the menopausal model, and confirmed effects, by means of the novel strain and previously reportedstrains, of alleviating menopausal symptoms, such as the inhibition of an increase in body fat, the inhibition of a decrease in bone mineral density, the inhibition of an increase in the pain sensitivity, and the alleviation of depression. Therefore, it is expected that the composition comprising theaccording to the present invention can be usable for a use of preventing, alleviating, or treating menopause.


Find Patent Forward Citations

Loading…